Regulation of fibrillar collagen-mediated smooth muscle cell proliferation in response to chemical stimuli by telomere reverse transcriptase through c-Myc

Biomaterials

Volumn 35, Issue 12, 2014, Pages 3829-3839

  Wang, Wei Li ^a   Yeh, Yi Ting ^a   Chen, Li Jing ^a   Chiu, Jeng Jiann ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

C Myc; Cell cycle; Fibrillar collagen; Human telomere reverse transcriptase; Smooth muscle cell

Indexed keywords

C-MYC; CELL CYCLE; FIBRILLAR COLLAGENS; REVERSE TRANSCRIPTASES; SMOOTH MUSCLE CELLS;

CELL PROLIFERATION; CHROMOSOMES; CYTOLOGY; FIBER OPTIC CHEMICAL SENSORS;

COLLAGEN;

COLLAGEN; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GUANINE; INTERLEUKIN 1BETA; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BINDING KINETICS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TELOMERE; UPREGULATION; WESTERN BLOTTING;

C-MYC; CELL CYCLE; FIBRILLAR COLLAGEN; HUMAN TELOMERE REVERSE TRANSCRIPTASE; SMOOTH MUSCLE CELL;

BASE SEQUENCE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DNA PRIMERS; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; TELOMERE;

EID: 84893773621     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.049     Document Type: Article

References (43)

1. Beamish J.A., He P., Kottke-Marchant K., Marchant R.E. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev 2010, 16:467-491.
2. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002, 8:1249-1256.
3. Raines E.W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol 2000, 81:173-182.
4. Chen C.N., Li Y.S., Yeh Y.T., Lee P.L., Usami S., Chien S., et al. Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells. Proc Natl Acad Sci U S A 2006, 103:2665-2670.
5. Yeh Y.T., Lee C.I., Lim S.H., Chen L.J., Wang W.L., Chuang Y.J., et al. Convergence of physical and chemical signaling in the modulation of vascular smooth muscle cell cycle and proliferation by fibrillar collagen-regulated P66Shc. Biomaterials 2012, 33:6728-6738.
6. Koyama H., Raines E.W., Bornfeldt K.E., Roberts J.M., Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 1996, 87:1069-1078.
7. Wang J.C., Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012, 111:245-259.
8. Harrington L., Zhou W., McPhail T., Oulton R., Yeung D.S., Mar V., et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997, 11:3109-3115.
9. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
10. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
11. Masutomi K., Hahn W.C. Telomerase and tumorigenesis. Cancer Lett 2003, 194:163-172.
12. Liu S.C., Wang S.S., Wu M.Z., Wu D.C., Yu F.J., Chen W.J., et al. Activation of telomerase and expression of human telomerase reverse transcriptase in coronary atherosclerosis. Cardiovasc Pathol 2005, 14:232-240.
13. Fuster J.J., Andres V. Telomere biology and cardiovascular disease. Circ Res 2006, 99:1167-1180.
14. Gartel A.L., Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 2003, 283:17-21.
15. Mateyak M.K., Obaya A.J., Sedivy J.M. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999, 19:4672-4683.
16. Sun L.Q., Cairns M.J., Gerlach W.L., Witherington C., Wang L., King A. Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme. JBiol Chem 1999, 274:17236-17241.
17. Inafuku M., Toda T., Okabe T., Shinjo A., Iwasaki H., Oku H. Expression of cell-cycle-regulating genes in the development of atherosclerosis in Japanese quail (Coturnix japonica). Poult Sci 2007, 86:1166-1173.
18. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., et al. Direct activation of TERT transcription by c-MYC. Nat Genet 1999, 21:220-224.
19. Kaul D., Gautam A., Varma S., Ahlawat A. Functional genomics of hTERT gene in leukemic myelopoiesis. Mol Cell Biochem 2008, 314:19-23.
20. Wang F., Podell E.R., Zaug A.J., Yang Y., Baciu P., Cech T.R., et al. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007, 445:506-510.
21. Paeschke K., Juranek S., Simonsson T., Hempel A., Rhodes D., Lipps H.J. Telomerase recruitment by the telomere end binding protein-beta facilitates G-quadruplex DNA unfolding in ciliates. Nat Struct Mol Biol 2008, 15:598-604.
22. Xin H., Liu D., Wan M., Safari A., Kim H., Sun W., et al. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007, 445:559-562.
23. Gonzalez V., Hurley L.H. The c-MYC NHE III(1): function and regulation. Annu Rev Pharmacol Toxicol 2010, 50:111-129.
24. Xu D., Popov N., Hou M., Wang Q., Bjorkholm M., Gruber A., et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A 2001, 98:3826-3831.
25. Lipps H.J., Rhodes D. G-quadruplex structures: invivo evidence and function. Trends Cell Biol 2009, 19:414-422.
26. Oganesian L., Graham M.E., Robinson P.J., Bryan T.M. Telomerase recognizes G-quadruplex and linear DNA as distinct substrates. Biochemistry 2007, 46:11279-11290.
27. Minamino T., Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ Res 2001, 89:237-243.
28. Choi J., Southworth L.K., Sarin K.Y., Venteicher A.S., Ma W., Chang W., et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 2008, 4:e10.
29. Kawauchi K., Ihjima K., Yamada O. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. JImmunol 2005, 174:5261-5269.
30. Kang S.S., Kwon T., Kwon D.Y., Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. JBiol Chem 1999, 274:13085-13090.
31. Zhou Z.Q., Hurlin P.J. The interplay between Mad and Myc in proliferation and differentiation. Trends Cell Biol 2001, 11:S10-S14.
32. Luscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 2001, 277:1-14.
33. Marin M.L., Gordon R.E., Veith F.J., Tulchin N., Panetta T.F. Distribution of c-myc oncoprotein in healthy and atherosclerotic human carotid arteries. JVasc Surg 1993, 18:170-176.
34. Banskota N.K., Taub R., Zellner K., King G.L. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 1989, 3:1183-1190.
35. Wagner A.J., Le Beau M.M., Diaz M.O., Hay N. Expression, regulation, and chromosomal localization of the Max gene. Proc Natl Acad Sci U S A 1992, 89:3111-3115.
36. Zhu J., Blenis J., Yuan J. Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci U S A 2008, 105:6584-6589.
37. Yu X., Zhen Y., Yang H., Wang H., Zhou Y., Wang E., et al. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell Death Dis 2013, 4:e634.
38. Fu D., Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell 2007, 28:773-785.
39. Michelotti E.F., Michelotti G.A., Aronsohn A.I., Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol 1996, 16:2350-2360.
40. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
41. Park J., Ha H., Seo J., Kim M.S., Kim H.J., Huh K.H., et al. Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. Am J Transplant 2004, 4:1982-1990.
42. Rani U.P., Kesavan R., Ganugula R., Avaneesh T., Kumar U.P., Reddy G.B., et al. Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats. JNutr Biochem 2013, 24:1830-1839.
43. ten F.H., Huntgeburth M., Wingler K., Schnitker J., Baumer A.T., Vantler M., et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 2006, 71:331-341.